N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
US9067963B2 · kind B2 · utility
23Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2013 |
| Grant date | Jun 30, 2015 |
| Priority date | — |
| Expiry date | Jul 31, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides N-alkyl 2-(disubstituted)alkynyladenosine-5′-uronamides and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.